Prolactin release following breast pump aspiration is less than that following suckling. The long-term effects of this decreased prolactin response are not yet known and therefore the use of the breast pump should be limited to selected cases and for the shortest possible time.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/BF02886691 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Gastroesophageal Reflux in Infants and Children: Diagnosis and Treatment.
Am Fam Physician
January 2025
Duke University School of Medicine, Durham, N.C.
Gastroesophageal reflux is a common physiologic event in infants in which gastric contents pass from the stomach into the esophagus. Gastroesophageal reflux may be asymptomatic or cause regurgitation or "spit up." This occurs daily in approximately 40% of infants.
View Article and Find Full Text PDFInvestigating the effect of yoga-based educational interventions on the volume and composition of breast milk in premature infant's mothers admitted to neonatal intensive care unit: A randomized controlled trial.
J Educ Health Promot
November 2024
Department of Biochemistry, School of Medicine, Babol University of Medical Sciences, Babol, Iran.
Background: This study examined the effects of yoga-based educational interventions on the volume and composition of breast milk in premature infants' mothers admitted to the neonatal intensive care unit (NICU).
Materials And Methods: A randomized controlled trial was conducted on 78 primiparous mothers whose premature infants were less than 34 weeks and were hospitalized in the NICU of Ayatollah Rouhani Hospital from February 2021 to November 2022. Mothers were assigned to a control group and an experimental group, that is, yoga, using the block randomization method.
Effectiveness of breast pumps in early postpartum breastfeeding for women after cesarean section: A systematic review.
Jpn J Nurs Sci
January 2025
Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan.
Aim: We sought to assess the effectiveness of using a breast pump for nipple stimulation to promote breastfeeding in the early postpartum period after c-section in women with full-term infants.
Methods: Selection criteria were individual and cluster randomized control trials and quasi-randomized control trials that compared using a breast pump combined with standard care to promote breastfeeding in the early postpartum period after c-section with standard care. In this systematic review, guided by the Cochrane Handbook, we conducted comprehensive searches across databases such as Medline, Embase, CINAHL, Cochrane Library, and PsycINFO (Search: April 22, 2024).
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin.
Int J Mol Sci
December 2024
Department of Biological Chemical and Pharmaceutical Science and Technology (STEBICEF), University of Palermo, 90128 Palermo, Italy.
The MCF-7R breast cancer cell line, developed by treating the parental MCF-7 cells with increasing doses of doxorubicin, serves as a model for studying acquired multidrug resistance (MDR). MDR is a major challenge in cancer therapy, often driven by overexpression of the efflux pump P-glycoprotein (P-gp) and epigenetic modifications. While many P-gp inhibitors show promise in vitro, their nonspecific effects on the efflux pump limit in vivo application.
View Article and Find Full Text PDFDrug-drug interactions between palbociclib and proton pump inhibitors in early breast cancer: an exploratory analysis of PALLAS (ABCSG-42/AFT-05/BIG-14-13/PrE0109).
ESMO Open
January 2025
Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
Background: Concomitant intake of proton pump inhibitors (PPIs) may create drug-drug interactions, potentially impacting efficacy of anticancer agents. In the phase III PALLAS trial, the addition of palbociclib capsules to standard adjuvant endocrine therapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer did not improve invasive disease-free survival (iDFS). We explored whether concomitant use of PPIs affected survival outcomes in patients treated with palbociclib in PALLAS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!